| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85198ac475d36103e3c53430febb85a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c8407fae1b83dca61d233cd8146221d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1709bb117791ac0eb0dc7436b55aa5a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d2f3471482e33582d524b57e57fa8d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_04420713d8ca0e51f499cd44298a4692
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6ac889a94b73b8e6bc7084eb9cd0f7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88068ef91137ae61711d8cef1128c02e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-085 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/E05B65-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B29C45-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H05K3-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/E05B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-102 |
| filingDate |
2004-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bc41159501197f8e3fb225da461a8fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f0d7f7413d408973fa18c8e9f4709d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c68273912f58f7c8ce17ebd9d95bf646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ebb4b45ff71f1fc4215b672e79b42e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_622f1dcb6f2776bda81a58b4ac8a226f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aab9ee4aa9bb3ed8e60fde0d07fa9d7a |
| publicationDate |
2005-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005041890-A2 |
| titleOfInvention |
Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same |
| abstract |
The present invention provides a composition and an improved single dose vaccine against E. rhusiopathiae and an improved single dose vaccine against E. rhusiopathiae and H. parasuis which provides one or more of the following: 1) confers effective immunity against E. rhusiopathiae and/or H. parasuis; 2) decreases the risk of developing clinical signs of E. rhusiopathiae and/or H. parasuis infection; 3) induces an immune response against E. rhusiopathiae and/or H. parasuis; and 4) has a DOI against E. rhusiopathiae and/or H. parasuis of at least four months. The composition or E. rhusiopathiae vaccine as well as the combined E. rhusiopathiae-H. parasuis composition or vaccine each includes a bacterial component of inactivated E. rhusiopathiae bacteria and a suitable adjuvant. The combined E. rhusiopathiae-H. parasuis composition or vaccine further includes an amount of H. parasuis antigen. The vaccines can be administered to animals in any conventional manner. The amount of the dose for intramuscular administration is preferably less than 5 ml. The amount of E. rhusiopathiae and/or H. parasuis antigen in each dose should be enough to induce an immune response in the animal receiving the vaccine or composition and will preferably confer effective immunity against and decrease the risk of developing clinical signs resulting from E. rhusiopathiae and/or H. parasuis infection for a suitable duration of immunity. |
| priorityDate |
2003-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |